- Anatomic Pathology Division, Children’s Hospital of Eastern Ontario (CHEO), University of Ottawa, ON, Ottawa, Canada
Thymus depletion is a usual finding in human-immunodeficiency virus (HIV) infected patients, but a refurbishment of the thymus function in children has been proposed in some virologic responders treated with multidrug combinations of antiretroviral agents (1–3). In addition, studies from children with acquired immunodeficiency syndrome (AIDS) have clarified the pathogenesis of some primary tissue lesions (2, 4, 5). These studies are highly relevant to understanding the direct and indirect sequels associated with HIV infection.
In the last two decades, we have observed a thrilling interest in pursuing the topic of the interaction between HIV and hematopoietic stem cells of progenitor origin (HSPCs, hematopoietic stem progenitor cells) (6). Despite the great interest and research, numerous aspects are still unclear. It remains ambiguous whether the hematopoietic stem cells of progenitor origin can behave as virologic reservoirs. In fact, it is known that some investigations have suggested that the latently infected stem cells are fundamental in the bone marrow of patients infected with HIV or suffering from AIDS. However, other authors have promoted negative results that have challenged such data’s reproducibility. Facing this dilemma, it is probably compulsory to start elucidating this controversy. Suppose an arm of HSPC studies of HIV infection entails dynamics investigations in the stages (both early and late) of the disease to recognize the influence on the pathogenesis of AIDS. In that case, reduced quantities and functional damage of multipotent cells with myeloid and lymphoid progenitor ancestry in HIV infection may promote indicators in hematology. Therefore, trace elements and supplementations have been targeted to exponentially boost the immunologic function of both healthy individuals and patients with different diseases.
Zinc (Zn) is an indispensable micronutrient with a re-discovered interest in nutritional medicine and supplementation (7). Zn is key to almost every aspect of the evolution of our human health. Zn, a transition metal, is grouped with cadmium and mercury in the periodic table. Zn is second only to iron as the most abundant trace mineral in humans in our body. Research has focused on the utility of this transition metal in the immunologic system (7–10). It seems that this trace element may boost immune function, soothe glycemia levels, and help keep cardiac, ocular, and cutaneous systems healthy, targeting the T-cell metabolism intimately (11–13).
T -cell receptor-derived excision circles (TRECs) are DNA portions in small circles generated in T-lymphocytes in a specific time. The period is their transition through the thymus as the T cells rearrange their T-cell receptor (TCR) genes (14–16). Thus, their occurrence implies the maturation of T lymphocytes. TRECs are reduced in severe combined immunodeficiency disease (SCID) and in other conditions associated with immunodeficiency, such as the Chromosome 22q11.2 Deletion (DiGeorge Syndrome) (15, 17–22). Recently, Iovino et al. (23) stated clearly that Zn supplementation after HSCT causes an increase in TRECs and CD4+ naïve lymphocytes. It also prevented the reactivation of the Torque Teno Virus (TTV), a universal virus with identified in more than half of the general human population substantially worldwide. It is considered a blood-borne virus with parenteral, sexual, mother-to-child, and other ways of transmission (24). Despite being proposed to be an etiologic agent of several non-oncological diseases (e.g., liver diseases, respiratory tract diseases, AIDS) and cancer, there has been no or poor support until now. Still, there is some evidence that TTV may play a role in developing autoimmune reactions (24).
The versatility of the thymus to generate naive T-lymphocytes exhibiting a vast range of T-cell receptor mixture is an essential premise to developing an efficient immune system able to recognize an extensive range of antigens throughout life. Naïve T cells need to be activated and expanded to generate memory T cells establishing the peripheral T cell repertoire by migrating from the thymic microenvironment to peripheral lymphoid tissue. Although the thymus, which is the central organ of the human body able to target the T lymphopoiesis, is highly susceptible to many insults, it also has an extraordinary capacity to regenerate after damage. Yet, the prolonged lymphopenia and delayed thymic reconstitution following HSCT negatively affect clinical outcomes, especially in the elderly. In this age group, the thymic gland has already undertaken size reduction, which is physiological in nature, decreasing its ability to generate new T-lymphocytes (3).
In a pilot study on Multiple Myeloma (MM) patients, who were eligible to auto-HSCT, Iovino et al. performed a preliminary or pilot investigation. They studied nine patients per group with or without Zn supplementation finalized the study to assess the tolerability of the therapy, the rate of adverse events (AE), and the sequels on the substitute immunological consequences. After HSCT, five patients initially had AEs judged to be caused by zinc supplementation. A posteriori, it has been identified that these AE may have been probably multifactorial. No severe AEs were reported. With regard to the immunological factors, no statistical differences were detected between the two groups at the time of the registration. An exception was noted with regard to the higher level at baseline of CD8+ central memory (CD8 + CM) (circulating CD8+ cells) in favor of the control group. The two groupings also did not differentiate in TRECs at baseline, but, remarkably, the control group showed higher values at the time-point before HSCT. There was no difference in TRECs in absolute number between the two groupings at days +30 and +100. TTV load remained low in both groups from baseline until day +30, but at day +100, the control group showed TTV replication higher levels of CD4 + CD45RA+ terminal effector (CD4 + TE), and a higher level of circulating CD4+ central memory (CD4 + CM). The data on the circular, single-stranded DNA TTV may be significant and harbinger of more studies in the future. The median average of circulating CD4+ T-lymphocytes (naïve) demonstrated no differences between the two groupings across timelines. However, CD4+ naïve lymphocytes and TRECs remarkably increased from day +30 through +100 in the Zn group only. The relative boost of TRECs concerning pre-HSCT levels reached a value of 6.1-fold in the Zn group, which is remarkably higher equated to the value of a 1.8-fold rise in the control group.
Recently, we identified some mechanisms underlying germline variations impairing the domain member 11 of the caspase recruitment 11 (CARD11)-B cell leukemia of chronic lymphocytic type 10 (BCL10)-mucosa-associated lymphatic tissue 1 (MALT1) or CBM complex (25). This complex is intimately connected with various human diseases, including SCID, allergy/atopy, and lymphoproliferative disorders. The CBM signalosome complex operates as a molecular “bridge” between antigen receptor signaling on the cell surface and the triggering of the nuclear factor-kappa B (NF-κB), a protein complex regulating DNA transcription, cytokine generation, and overall cell survival. In addition, there is the triggering of two signaling axes, i.e., JNK or c-Jun N-terminal kinases, and mTORC1 or mammalian target of rapamycin complex 1. JNKs are a group of protein kinases that exhibit a central role in stress signaling pathways NF-κB and Activator Protein 1 (AP-1) transcriptional factors that regulate the expression of numerous genes involved in angiogenesis, autochthonous tumor growth, and tumor metastasis. Treatment of cancer cell lines with zinc reduces the expression of growth factors, interleukins, and matrix proteins. Thus, Zn reduces the expression of ICAM-1 or, also known as, intercellular adhesion molecule of type 1. In addition, Zn represses tumor cell invasiveness and, substantially, the cellular adhesion (26). Also, Zn deficiency-triggered stress of oxidative type could impact cell signaling, including mainly transcription factors containing Zn finger motifs. In addition, Zn may also act on other oxidant-sensitive transcription factors such as the NF-κB mentioned above and AP-1. An impairment of the nuclear transport of the active transcription factor may lead to a small amount of NF-κB-dependent genes being expressed that could be favorably involved in various steps of Zn deficiency-associated pathology, underlining the prominent role of Zn in this process, which seems to be paramount and critical in senility and in human conditions and syndromes associated with an accelerated process of aging featuring changes in biological, physiological, and behavioral processes (27).
Zinc deficiency is not a trivial absence of a chemical element. Clinically, it causes depression of the immune system and progressive and accelerated atrophy of the thymus (28). In a consequence of it, there is a decrease in circulating recent thymic emigrants (RTE). It is true that no statistical differences were found in baseline serum levels of zinc. Nevertheless, Iovino et al.’s investigations are praiseworthy. Although they pointed out that their Droplet Digital PCR based study should be considered a pilot investigation only and a larger number of patients should be enrolled in randomized clinical trials with an associated animal model for mechanistic insights are necessary, it is worthy that the supplementation of this element can be attempted to try to promote the thymic regeneration after damage. There was a significant increase of CD4+ naïve cells and TRECs from day +30 until day +100 only in the zinc-treated group. TRECs are the most accurate measurement for evaluating the functionality of the thymus and the production of RTEs in practice (29). Therefore, there is substantial some good optimism because the CD4+ naïve cells and TRECs at day +100 clearly indicate an augmentation of the production of RTEs triggered by zinc supplementation. Substantially, higher levels of RTEs after allogeneic HSCT are correlated with an improvement in the prognosis of these patients, who experience a decreased risk of infection and a relatively lower ratio of onset of graft versus host disease (GvHD) (30–32).
In our opinion, there is some evidence that Zn may be of benefit to patients receiving HSCT and in individuals affected with other immunologic deficiencies, such as CARD11 deficiency (25, 33). However, randomized clinical trials with numerous patients and animal models for mechanistic data are warranted. It is crucial to set up such trials in the future, starting multinational cooperation and liaising effectively with experts in veterinary pathology. Overall, there is a reasonable ground that zinc supplementation may be beneficial. It can also be hypothesized that an inappropriate or inadequate Zn reserve may accelerate cell aging and potentially promote carcinogenesis due to unsatisfactory immunologic surveillance.
Author Contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Funding
Dr. Sergi’s research has been funded by the generosity of the Stollery Children’s Hospital Foundation and supporters of the Lois Hole Hospital for Women through the Women and Children’s Health Research Institute (WCHRI, Grant ID #: 2096), Natural Science Foundation of Hubei Province for Hubei University of Technology (100-Talent Grant for Recruitment Program of Foreign Experts Total Funding: Digital PCR and NGS-based diagnosis for infection and oncology, 2017-2022), Österreichische Krebshilfe Tyrol (Krebsgesellschaft Tirol, Austrian Tyrolean Cancer Research Institute, 2007 and 2009 - “DMBTI and cholangiocellular carcinomas” and “Hsp70 and HSPBP1 in carcinomas of the pancreas”), Austrian Research Fund (Fonds zur Förderung der wissenschaftlichen Forschung, FWF, Grant ID L313-B13), Canadian Foundation for Women's Health (“Early Fetal Heart-RES0000928”), Cancer Research Society (von Willebrand factor gene expression in cancer cells), Canadian Institutes of Health Research (Omega-3 Fatty Acids for Treatment of Intestinal Failure Associated Liver Disease: A Translational Research Study, 2011-2014, CIHR 232514), and the Saudi Cultural Bureau, Ottawa, Canada. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Conflict of Interest
The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Cascio A, Colomba C, Di Carlo P, Serra N, Lo Re G, Gambino A, et al. Low Bone Mineral Density in HIV-Positive Young Italians and Migrants. PloS One (2020) 15(9):e0237984. doi: 10.1371/journal.pone.0237984
2. Meraviglia S, Di Carlo P, Pampinella D, Guadagnino G, Presti EL, Orlando V, et al. T-Cell Subsets (TCM, TEM, TEMRA) and Poly-Functional Immune Response in Patients With Human Immunodeficiency Virus (HIV) Infection and Different T-CD4 Cell Response. Ann Clin Lab Sci (2019) 49(4):519–28.
3. Brunner J, Boehler T, Ehemann V, Kassam S, Otto H, Sergi C. Decreased Apoptosis Despite Severe CD4 Depletion in the Thymus of a Human Immunodeficiency Virus-1 Infected Child. Klin Padiatr (2011) 223(4):246–8. doi: 10.1055/s-0030-1270514
4. Coelho AVC, Gratton R, Melo JPB, Andrade-Santos JL, Guimaraes RL, Crovella S, et al. HIV-1 Infection Transcriptomics: Meta-Analysis of CD4+ T Cells Gene Expression Profiles. Viruses (2021) 13(2):244. doi: 10.3390/v13020244
5. Sergi C, Roth SU, Adam S, Otto HF. Mapping a Method for Systematically Reviewing the Medical Literature: A Helpful Checklist Postmortem Protocol of Human Immunodeficiency Virus (HIV)-Related Pathology in Childhood. Pathologica (2001) 93(3):201–7.
6. Tsukamoto T. Hematopoietic Stem/Progenitor Cells and the Pathogenesis of HIV/AIDS. Front Cell Infect Microbiol (2020) 10:60. doi: 10.3389/fcimb.2020.00060
7. Rees G, Brough L, Orsatti GM, Lodge A, Walker S. Do Micronutrient and Omega-3 Fatty Acid Supplements Affect Human Maternal Immunity During Pregnancy? A Scoping Review. Nutrients (2022) 14(2):367. doi: 10.3390/nu14020367
8. Maunders EA, Ganio K, Hayes AJ, Neville SL, Davies MR, Strugnell RA, et al. The Role of Znta in Klebsiella Pneumoniae Zinc Homeostasis. Microbiol Spectr (2022) 10(1):e0177321. doi: 10.1128/spectrum.01773-21
9. Kim B, Kim HY, Yoon BR, Yeo J, In Jung J, Yu KS, et al. Cytoplasmic Zinc Promotes IL-1beta Production by Monocytes and Macrophages Through Mtorc1-Induced Glycolysis in Rheumatoid Arthritis. Sci Signal (2022) 15(716):eabi7400. doi: 10.1126/scisignal.abi7400
10. Baarz BR, Rink L. Rebalancing the Unbalanced Aged Immune System - a Special Focus on Zinc. Ageing Res Rev (2022) 74:101541. doi: 10.1016/j.arr.2021.101541
11. Kim B, Kim HY, Lee WW. Zap70 Regulates TCR-Mediated Zip6 Activation at the Immunological Synapse. Front Immunol (2021) 12:687367. doi: 10.3389/fimmu.2021.687367
12. Georgiev H, Peng C, Huggins MA, Jameson SC, Hogquist KA. Classical MHC Expression by DP Thymocytes Impairs the Selection of Non-Classical MHC Restricted Innate-Like T Cells. Nat Commun (2021) 12(1):2308. doi: 10.1038/s41467-021-22589-z
13. Harsha Krovi S, Zhang J, Michaels-Foster MJ, Brunetti T, Loh L, Scott-Browne J, et al. Thymic Inkt Single Cell Analyses Unmask the Common Developmental Program of Mouse Innate T Cells. Nat Commun (2020) 11(1):6238. doi: 10.1038/s41467-020-20073-8
14. Cavalcanti NV, Palmeira P, Jatene MB, de Barros Dorna M, Carneiro-Sampaio M. Early Thymectomy Is Associated With Long-Term Impairment of the Immune System: A Systematic Review. Front Immunol (2021) 12:774780. doi: 10.3389/fimmu.2021.774780
15. Xiao F, Lu Y, Wu B, Liu B, Li G, Zhang P, et al. High-Frequency Exon Deletion of DNA Cross-Link Repair 1c Accounting for Severe Combined Immunodeficiency may be Missed by Whole-Exome Sequencing. Front Genet (2021) 12:677748:677748. doi: 10.3389/fgene.2021.677748
16. Shinwari K, Bolkov M, Tuzankina IA, Chereshnev VA. Newborn Screening Through TREC, TREC/KREC System for Primary Immunodeficiency With Limitation of TREC/KREC. Comprehensive Review. Antiinflamm Antiallergy Agents Med Chem (2021) 20(2):132–49. doi: 10.2174/1871523019999200730171600
17. Bhalla P, Wysocki CA, van Oers NSC. Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models. Front Immunol (2020) 11:830. doi: 10.3389/fimmu.2020.00830
18. Gul KA, Strand J, Pettersen RD, Brun H, Abrahamsen TG. T-Cell Receptor Excision Circles in Newborns With Heart Defects. Pediatr Cardiol (2020) 41(4):809–15. doi: 10.1007/s00246-020-02317-y
19. Amatuni GS, Currier RJ, Church JA, Bishop T, Grimbacher E, Nguyen AA, et al. Newborn Screening for Severe Combined Immunodeficiency and T-Cell Lymphopenia in California, 2010-2017. Pediatrics (2019) 143(2):e20182300. doi: 10.1542/peds.2018-2300
20. Kuo CY, Signer R, Saitta SC. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (Digeorge Syndrome). Curr Allergy Asthma Rep (2018) 18(12):75. doi: 10.1007/s11882-018-0823-5
21. Gul KA, Overland T, Osnes L, Baumbusch LO, Pettersen RD, Lima K, et al. Neonatal Levels of T-Cell Receptor Excision Circles (TREC) in Patients With 22q11.2 Deletion Syndrome and Later Disease Features. J Clin Immunol (2015) 35(4):408–15. doi: 10.1007/s10875-015-0153-5
22. Sergi C, Serpi M, Muller-Navia J, Schnabel PA, Hagl S, Otto HF, et al. CATCH 22 Syndrome: Report of 7 Infants With Follow-Up Data and Review of the Recent Advancements in the Genetic Knowledge of the Locus 22q11. Pathologica (1999) 91(3):166–72.
23. Iovino L, Mazziotta F, Carulli G, Guerrini F, Morganti R, Mazzotti V, et al. High-Dose Zinc Oral Supplementation After Stem Cell Transplantation Causes an Increase of Trecs and CD4+ Naive Lymphocytes and Prevents TTV Reactivation. Leuk Res (2018) 70:20–4. doi: 10.1016/j.leukres.2018.04.016
24. Vasilyev EV, Trofimov DY, Tonevitsky AG, Ilinsky VV, Korostin DO, Rebrikov DV. Torque Teno Virus (TTV) Distribution in Healthy Russian Population. Virol J (2009) 6:134. doi: 10.1186/1743-422X-6-134
25. Lu HY, Sharma M, Sharma AA, Lacson A, Szpurko A, Luider J, et al. Mechanistic Understanding of the Combined Immunodeficiency in Complete Human CARD11 Deficiency. J Allergy Clin Immunol (2021) 148(6):1559–74.e13. doi: 10.1016/j.jaci.2021.04.006
26. Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Diverse Effects of Zinc on NF-Kappab and AP-1 Transcription Factors: Implications for Prostate Cancer Progression. Carcinogenesis (2006) 27(10):1980–90. doi: 10.1093/carcin/bgl034
27. Herbein G, Varin A, Fulop T. NF-Kappab, AP-1, Zinc-Deficiency and Aging. Biogerontology (2006) 7(5-6):409–19. doi: 10.1007/s10522-006-9056-4
28. Hosea HJ, Rector ES, Taylor CG. Zinc-Deficient Rats Have Fewer Recent Thymic Emigrant (CD90+) T Lymphocytes in Spleen and Blood. J Nutr (2003) 133(12):4239–42. doi: 10.1093/jn/133.12.4239
29. Ringhoffer S, Rojewski M, Dohner H, Bunjes D. Ringhoffer M. T-Cell Reconstitution After Allogeneic Stem Cell Transplantation: Assessment by Measurement of the Sjtrec/Betatrec Ratio and Thymic Naive T Cells. Haematologica (2013) 98(10):1600–8. doi: 10.3324/haematol.2012.072264
30. Przybylski GK, Kreuzer KA, Siegert W, Schmidt CA. No Recovery of T-Cell Receptor Excision Circles (Trecs) After Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Is Correlated With the Onset of Gvhd. J Appl Genet (2007) 48(4):397–404. doi: 10.1007/BF03195239
31. Uzunel M, Sairafi D, Remberger M, Mattsson J. Uhlin M. T-Cell Receptor Excision Circle Levels After Allogeneic Stem Cell Transplantation Are Predictive of Relapse in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome. Stem Cells Dev (2014) 23(14):1559–67. doi: 10.1089/scd.2013.0588
32. Lewin SR, Heller G, Zhang L, Rodrigues E, Skulsky E, van den Brink MR, et al. Direct Evidence for New T-Cell Generation by Patients After Either T-Cell-Depleted or Unmodified Allogeneic Hematopoietic Stem Cell Transplantations. Blood (2002) 100(6):2235–42. doi: 10.1182/blood.V100.6.2235
Keywords: zinc, supplementation, T-cell, metabolism, thymus
Citation: Sergi CM (2022) The Role of Zinc in the T-Cell Metabolism in Infection Requires Further Investigation - An Opinion. Front. Immunol. 13:865504. doi: 10.3389/fimmu.2022.865504
Received: 29 January 2022; Accepted: 18 February 2022;
Published: 10 March 2022.
Edited by:
Jin-fu Xu, Tongji University, ChinaReviewed by:
Bjørn Steen Skålhegg, University of Oslo, NorwayCopyright © 2022 Sergi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Consolato M. Sergi, csergi@cheo.on.ca